FR-229934 is a PDE V inhibitor extracted from patent WO2019130052A1. FR-229934 can be used for the research of pulmonary arterial hypertension and erectile dysfunction[1].
[1]. PANDYA J, et, al. Liquid oral formulations for pde v inhibitors. WO2019130052A1.
















